The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Apr 2021
Historique:
received: 12 02 2021
revised: 30 03 2021
accepted: 03 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 14 5 2021
Statut: epublish

Résumé

Here, we review the haloacid dehalogenase (HAD) class of protein phosphatases, with a particular emphasis on an unusual group of enzymes, the eyes absent (EYA) family. EYA proteins have the unique distinction of being structurally and mechanistically classified as HAD enzymes, yet, unlike other HAD phosphatases, they are protein tyrosine phosphatases (PTPs). Further, the EYA proteins are unique among the 107 classical PTPs in the human genome because they do not use a Cysteine residue as a nucleophile in the dephosphorylation reaction. We will provide an overview of HAD phosphatase structure-function, describe unique features of the EYA family and their tyrosine phosphatase activity, provide a brief summary of the known substrates and cellular functions of the EYA proteins, and speculate about the evolutionary origins of the EYA family of proteins.

Identifiants

pubmed: 33920226
pii: ijms22083925
doi: 10.3390/ijms22083925
pmc: PMC8069645
pii:
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Nuclear Proteins 0
Hydrolases EC 3.-
EYA1 protein, human EC 3.1.3.48
Protein Tyrosine Phosphatases EC 3.1.3.48
2-haloacid dehalogenase EC 3.8.1.2
Cysteine K848JZ4886

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA207068
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL152094
Pays : United States
Organisme : NCI NIH HHS
ID : CA207068
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL152094
Pays : United States

Références

Cell Mol Life Sci. 2013 Jun;70(11):1897-913
pubmed: 22971774
Dev Neurosci. 2020;42(5-6):170-186
pubmed: 33472197
Mol Cell. 2005 Mar 4;17(5):657-70
pubmed: 15749016
PLoS One. 2013 Dec 18;8(12):e84582
pubmed: 24367676
J Clin Invest. 2014 Aug;124(8):3378-90
pubmed: 24960160
Mol Cancer Ther. 2018 Aug;17(8):1659-1669
pubmed: 29802120
Nature. 2003 Nov 20;426(6964):295-8
pubmed: 14628052
Trends Genet. 2005 Mar;21(3):163-71
pubmed: 15734575
Dev Cell. 2015 Apr 6;33(1):22-35
pubmed: 25816987
Sci Rep. 2018 Feb 13;8(1):2910
pubmed: 29440662
J Biol Chem. 2009 Jun 12;284(24):16066-16070
pubmed: 19351884
FASEB J. 2010 Feb;24(2):560-9
pubmed: 19858093
Nat Commun. 2019 Sep 12;10(1):4143
pubmed: 31515519
Nature. 2009 Apr 2;458(7238):591-6
pubmed: 19234442
Nature. 2008 Feb 14;451(7180):783-8
pubmed: 18273011
Dev Dyn. 2007 Jun;236(6):1526-34
pubmed: 17477401
Annu Rev Biochem. 2007;76:513-38
pubmed: 17341163
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
PLoS One. 2012;7(4):e34806
pubmed: 22545090
Biochemistry. 2005 Jan 18;44(2):751-8
pubmed: 15641802
Dev Cell. 2012 Feb 14;22(2):377-90
pubmed: 22340499
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1558-63
pubmed: 12574510
J Mol Biol. 2006 Sep 1;361(5):1003-34
pubmed: 16889794
PLoS One. 2017 Nov 6;12(11):e0187546
pubmed: 29108015
Crit Rev Biochem Mol Biol. 2020 Aug;55(4):372-385
pubmed: 32727223
Mamm Genome. 1997 Jul;8(7):479-85
pubmed: 9195991
Nat Commun. 2018 Mar 13;9(1):1047
pubmed: 29535359
Sci Signal. 2009 Dec 08;2(100):re9
pubmed: 19996458
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11974-9
pubmed: 9342347
Crit Rev Biochem Mol Biol. 1998;33(1):1-52
pubmed: 9543627
Biochem J. 2009 Jan 15;417(2):401-9
pubmed: 19099538
Mol Cell Biol. 2016 Dec 19;37(1):
pubmed: 27795300
Nature. 2003 Nov 20;426(6964):299-302
pubmed: 14628053
Mol Cell Biol. 1999 Oct;19(10):6815-24
pubmed: 10490620
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1552-7
pubmed: 12574508
Nature. 2009 Jan 1;457(7225):57-62
pubmed: 19092802
Nature. 2009 Jul 23;460(7254):520-4
pubmed: 19561593
FEBS Lett. 2011 Sep 2;585(17):2714-9
pubmed: 21821028
Biol Direct. 2012 Apr 17;7:12
pubmed: 22510480
Mol Gen Genet. 1999 Aug;262(1):131-8
pubmed: 10503544
Am J Pathol. 2016 Mar;186(3):568-78
pubmed: 26765957
Cell. 1993 Feb 12;72(3):379-95
pubmed: 8431945
FEBS J. 2013 Jan;280(2):549-71
pubmed: 22607316
Sci Rep. 2016 Mar 16;6:23228
pubmed: 26980695
PLoS One. 2012;7(8):e42725
pubmed: 22916150

Auteurs

Kaushik Roychoudhury (K)

Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.

Rashmi S Hegde (RS)

Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH